1. Effects of Prehospital Thrombolysis in Stroke Patients With Prestroke Dependency
- Author
-
Kersten Villringer, Heinrich J. Audebert, Michal Rozanski, Christian H. Nolte, Tim Bastian Braemswig, Matthias Endres, Frederik Geisler, Ulrike Grittner, Katja Zieschang, Hebun Erdur, Jochen B. Fiebach, Matthias Wendt, Joachim E. Weber, Sabina Kaczmarek, Martin Ebinger, Jan F. Scheitz, and Alexander Kunz
- Subjects
Male ,medicine.medical_specialty ,Activities of daily living ,Stroke patient ,medicine.medical_treatment ,030204 cardiovascular system & hematology ,03 medical and health sciences ,0302 clinical medicine ,mortality [Intracranial Hemorrhages] ,Humans ,Medicine ,Thrombolytic Therapy ,ddc:610 ,Registries ,mortality [Stroke] ,diagnosis [Intracranial Hemorrhages] ,Aged ,Retrospective Studies ,Aged, 80 and over ,Advanced and Specialized Nursing ,business.industry ,Thrombolysis ,diagnosis [Stroke] ,Prehospital thrombolysis ,drug therapy [Stroke] ,Hospitalization ,Stroke ,Emergency medicine ,Ischemic stroke ,Female ,drug therapy [Intracranial Hemorrhages] ,Neurology (clinical) ,Cardiology and Cardiovascular Medicine ,business ,Intracranial Hemorrhages ,030217 neurology & neurosurgery - Abstract
Background and Purpose— Data on effects of intravenous thrombolysis on outcome of patients with ischemic stroke who are dependent on assistance in activities of daily living prestroke are scarce. Recent registry based analyses in activities of daily –independent patients suggest that earlier start of intravenous thrombolysis in the prehospital setting leads to better outcomes when compared with the treatment start in hospital. We evaluated whether these observations can be corroborated in patients with prestroke dependency. Methods— This observational, retrospective analysis included all patients with acute ischemic stroke depending on assistance before stroke who received intravenous thrombolysis either on the Stroke Emergency Mobile (STEMO) or through conventional in-hospital care (CC) in a tertiary stroke center (Charité, Campus Benjamin Franklin, Berlin) during routine care. Prespecified outcomes were modified Rankin Scale scores of 0 to 3 and survival at 3 months, as well as symptomatic intracranial hemorrhage. Outcomes were adjusted in multivariable logistic regression. Results— Between February 2011 and March 2015, 122 of 427 patients (28%) treated on STEMO and 142 of 505 patients (28%) treated via CC needed assistance before stroke. Median onset-to-treatment times were 97 (interquartile range, 69–159; STEMO) and 135 (interquartile range, 98–184; CC; P P =0.01) and 86 (70%, STEMO) versus 85 (60%, CC) patients were alive ( P =0.07). After adjustment, STEMO care was favorable with respect to modified Rankin Scale scores of 0 to 3 (odds ratio, 1.99; 95% confidence interval, 1.02–3.87; P =0.042) with a nonsignificant result for survival (odds ratio, 1.73; 95% confidence interval, 0.95–3.16; P =0.07). Symptomatic intracranial hemorrhage occurred in 5 STEMO versus 12 CC patients (4.2% versus 8.5%; P =0.167). Conclusions— The results of this study suggest that earlier, prehospital (as compared with in-hospital) start of intravenous thrombolysis in acute ischemic stroke may translate into better clinical outcome in patients with prestroke dependency. Clinical Trial Registration— URL: http://www.clinicaltrials.gov . Unique identifier: NCT02358772.
- Published
- 2018
- Full Text
- View/download PDF